FSTX - F-star Therapeutics EPS beats by $0.08 beats on revenue May, 17 2021 08:06 AM F-star Therapeutics Inc Com F-star Therapeutics (FSTX): Q1 GAAP EPS of -$1.08 beats by $0.08.Revenue of $2.92M (+114.7% Y/Y) beats by $1.72M.Press Release For further details see: F-star Therapeutics EPS beats by $0.08, beats on revenue